The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells

• Irina Gurt,

  Affiliation Endocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Hanna Artsi,

  Affiliation Endocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Einav Cohen-Kfir,

  Current address: Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

  Affiliation Endocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Gilad Hamdani,

  Current address: Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America.

  Affiliation Endocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Gal Ben-Shalom,

  Affiliation Endocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Ben Feinstein,

  Affiliation The Einstein Institute of Mathematics; The Hebrew University of Jerusalem, Jerusalem, Israel

  ⨯
• Madi El-Haj,

  Affiliation Department of Orthopedics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Rivka Dresner-Pollak

  * E-mail: rivkap@hadassah.org.il

  Affiliation Endocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯